Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin DiFrancesco

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Bioanalysis|November 22, 2014
Adding value to antiretroviral proficiency testingRobin DiFrancesco, Charlene R Taylor, Susan L Rosenkranz, et al.
African Journal of Laboratory Medicine|June 18, 2019
Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited settingFaithful Makita-Chingombe, Andrew J Ocque, Robin DiFrancesco, et al.
Therapeutic Drug Monitoring|May 6, 2011
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disordersQing Ma, Barry S Zingman, Amneris E Luque, et al.
Journal of Clinical Pharmacology|August 3, 2013
Sex differences in cyclosporine pharmacokinetics and ABCB1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipientsKathleen M Tornatore, Daniel Brazeau, Kiran Dole, et al.
Cost Effectiveness and Resource Allocation : C/E|November 11, 2021
Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained settingCharles C Maponga, Tsitsi G Monera-Penduka, Takudzwa J Mtisi, et al.
Antimicrobial Agents and Chemotherapy|February 7, 2007
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaksOlanrewaju Okusanya, Alan Forrest, Robin DiFrancesco, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 30, 2007
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance usersRobin DiFrancesco, Margaret A Fischl, Julie Donnelly, et al.
Journal of Neurovirology|June 6, 2013
Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patientsQing Ma, Harris A Gelbard, Sanjay B Maggirwar, et al.
The American Journal on Addictions|October 15, 2013
Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolismElinore F McCance-Katz, Valerie A Gruber, George Beatty, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling TechniquesCharles S Venuto, Marianthi Markatou, Yvonne Woolwine-Cunningham, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Bioanalysis|November 22, 2014
Adding value to antiretroviral proficiency testingRobin DiFrancesco, Charlene R Taylor, Susan L Rosenkranz, et al.
African Journal of Laboratory Medicine|June 18, 2019
Development and validation of a high performance liquid chromatography method to determine nevirapine in plasma in a resource-limited settingFaithful Makita-Chingombe, Andrew J Ocque, Robin DiFrancesco, et al.
Therapeutic Drug Monitoring|May 6, 2011
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disordersQing Ma, Barry S Zingman, Amneris E Luque, et al.
Journal of Clinical Pharmacology|August 3, 2013
Sex differences in cyclosporine pharmacokinetics and ABCB1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipientsKathleen M Tornatore, Daniel Brazeau, Kiran Dole, et al.
Cost Effectiveness and Resource Allocation : C/E|November 11, 2021
Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained settingCharles C Maponga, Tsitsi G Monera-Penduka, Takudzwa J Mtisi, et al.
Antimicrobial Agents and Chemotherapy|February 7, 2007
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaksOlanrewaju Okusanya, Alan Forrest, Robin DiFrancesco, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 30, 2007
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance usersRobin DiFrancesco, Margaret A Fischl, Julie Donnelly, et al.
Journal of Neurovirology|June 6, 2013
Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patientsQing Ma, Harris A Gelbard, Sanjay B Maggirwar, et al.
The American Journal on Addictions|October 15, 2013
Interaction of disulfiram with antiretroviral medications: efavirenz increases while atazanavir decreases disulfiram effect on enzymes of alcohol metabolismElinore F McCance-Katz, Valerie A Gruber, George Beatty, et al.
Antimicrobial Agents and Chemotherapy|March 8, 2017
Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling TechniquesCharles S Venuto, Marianthi Markatou, Yvonne Woolwine-Cunningham, et al.
Pageof 6